Sec Form 4 Filing - Kummeth Charles R. @ BIO-TECHNE Corp - 2016-08-18

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Kummeth Charles R. 2. Issuer Name and Ticker or Trading Symbol BIO-TECHNE Corp [ TECH] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) 614 MCKINLEY PLACE NE 3. Date of Earliest Transaction (MM/DD/YY) 08/18/2016 (Street) MINNEAPOLIS, MN55413 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/18/2016 A 16,653 A $ 0 61,030 ( 1 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 67.46 ( 2 ) 04/01/2020 Common Stock 65,000 65,000 D Stock Option (Right to Buy) $ 67.46 ( 3 ) 04/01/2020 Common Stock 50,000 50,000 D Stock Option (Right to Buy) $ 86.25 ( 4 ) 04/01/2021 Common Stock 46,316 46,316 D Stock Option (Right to Buy) $ 94.35 ( 5 ) 08/12/2021 Common Stock 80,460 80,460 D Restricted Stock Unit ( 7 ) ( 5 ) ( 5 ) Common Stock 11,129 11,129 D Stock Option (Right to Buy) $ 108.49 ( 6 ) 08/07/2022 Common Stock 79,517 79,517 D Stock Option (Right to Buy) $ 108.49 ( 8 ) 08/07/2022 Common Stock 119,275 119,275 D Restricted Stock Unit ( 7 ) ( 8 ) ( 8 ) Common Stock 17,283 17,283 D Stock Option (Right to Buy) $ 106.59 08/18/2016 A 102,779 ( 9 ) 08/18/2023 Common Stock 102,779 $ 0 102,779 D Stock Option (Right to Buy) $ 106.59 08/18/2016 A 154,169 ( 10 ) 08/18/2023 Common Stock 154,169 $ 0 154,169 D Restricted Stock Unit ( 7 ) 08/18/2016 A 24,979 ( 10 ) ( 10 ) Common Stock 24,979 $ 0 24,979 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Kummeth Charles R. 614 MCKINLEY PLACE NE MINNEAPOLIS, MN55413 X Chief Executive Officer Signatures /s/ Elizabeth M. Dunshee as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed. 08/22/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Includes (i) 2,551 shares for which the risk of forfeiture will lapse with respect to 2,551 shares on April 1, 2017; (ii) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; (iii) 7,682 shares for which the risks of forfeiture will lapse with respect to 3,841 shares on each of August 7, 2017 and August 7, 2018; and (iv) 16,653 shares for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2017, August 18, 2018 and August 18, 2019. ( 2 )The option will vest pursuant to the following schedule: 8,125 shares on October 1, 2013, 1,354 shares on the first day of each month for the period beginning November 1, 2013 and ending M arch 1, 2017, and 1,361 shares on April 1, 2017. ( 3 )Fully exercisable pursuant to achievement of performance goals. ( 4 )The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018. ( 5 )Vests in full or in part if certain performance goals are achieved during each of the 2015, 2016 and 2017 fiscal years. ( 6 )19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019. ( 7 )Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. ( 8 )Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). ( 9 )Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20. ( 10 )Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.